Detalhe da pesquisa
1.
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210).
Cytotherapy
; 26(1): 25-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897472
2.
Donor selection for adoptive cell therapy with CD45RA- memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release.
Cytotherapy
; 25(3): 330-340, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585293
3.
Familial CD45RA- T cells to treat severe refractory infections in immunocompromised patients.
Front Med (Lausanne)
; 10: 1083215, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36844219
4.
Rationale for combined therapies in severe-to-critical COVID-19 patients.
Front Immunol
; 14: 1232472, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767093
5.
Diversity of NKG2C genotypes in a European population: Conserved and recombinant haplotypes in the coding, promoter, and 3'-untranslated regions.
HLA
; 100(5): 469-478, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802353
6.
FCGR Genetic Variation in Two Populations From Ecuador Highlands-Extensive Copy-Number Variation, Distinctive Distribution of Functional Polymorphisms, and a Novel, Locally Common, Chimeric FCGR3B/A (CD16B/A) Gene.
Front Immunol
; 12: 615645, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108956
7.
A simple genotyping method for CD247 3'-untranslated region polymorphism rs1052231 and characterization of a reference cell panel.
HLA
; 98(3): 218-222, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233083